AzTrials
AzTrials

Eating BehaviorNCT04510883

Usage and Health Effects of Embodied Conversational Agents Among Older Adults

A study testing PACO and Waiting list + PACO in people with Eating Behavior and Loneliness, run by Wageningen University and Research at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Rationale: Embodied Conversational Agents (ECAs), could be a highly effective medium to address health behaviour change among older adults. As compliance to health advice is important for positive health outcomes, successful design of persuasive ECAs can have huge health benefits. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Eating Behavior, Loneliness, Technology Use
What is being tested?
PACO and Waiting list + PACO
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 siteNetherlands
Study dates
13 Jul 2020to 30 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Living independently at home
  • Living without a partner
  • No paid profession and at least 65 years of age
  • Dutch speaking
  • Able to use a tablet or computer
  • Internet connection at home

Who cannot join

  • Not willing to provide inform consent

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Wageningen University & Research

    Wageningen, Gelderland, 6706 KN

Other trials in Netherlands

About this study

Rationale: Embodied Conversational Agents (ECAs), could be a highly effective medium to address health behaviour change among older adults. As compliance to health advice is important for positive health outcomes, successful design of persuasive ECAs can have huge health benefits. However, insights in the mechanisms underlying usage and health behaviour change via ECAs are lacking.

Objective: The objective is to unravel the mechanisms behind the use of an ECA intervention, and understand the mechanism behind the observed behaviour change

Read more

Study design: A randomized staggered-entry waitlist-controlled trial will be carried out.

Study population: The study population consist of Dutch-speaking older adults, who live independently, are without partner, are retired, 65+ and possess basic computer skills.

Intervention: The application PACO has been created for (and with) older adults with the goal to motivate them to improve their eating behaviour and decrease their feelings of loneliness.

Main study parameters/endpoints: The main study parameters are use, loneliness, and eating behaviour.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Subjects are not exposed to any risks, nor have they any costs. They do have to fill in questionnaires and use the application. The duration and data collection moments are needed to gain a fine-grained understanding of the use, relationship development and health change process. For subjects, the main benefit is to gain insight in their health behaviour via the PACO-application. Although this might be experienced as confronting by some. The technology was developed based on sound theories, with input from the target group, so the investigators expect positive experiences and an improvement in participants loneliness and eating behaviour. However, this can only be proven after the study.

Being tested
PACO, Waiting list + PACO
Keywords
eHealth, Embodied Conversational Agent, Technology use
Medical subject headings
Feeding Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PACOBehavioural

    The intervention is a fully-automated web-based eHealth application in which two embodied conversational agents engage in dialogue with older adults in order to motivate them towards dietary behavior change and decrease loneliness. The application consists of five different modules, each one applying different behavior change techniques.

  • Waiting list + PACOBehavioural

    Waiting list + PACO

Study groups in NCT04510883
Study groupRoleWhat they receive
PACOExperimentalParticipants are asked to use the intervention for eight weeks.
Receives: Behavioral: PACO
Waiting list + PACOOtherParticipants receive the same intervention, but only after a waiting period of four weeks.
Receives: Behavioral: Waiting list + PACO

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Logdata on use application

    Amount of time spend on the application during the 8 weeks intervention period

    Measured: 8 weeks

  2. Change in De Jong Gierveld Loneliness Scale

    Score from 1-5, higher score means a better outcome.

    Measured: Four weeks before intervention to eight weeks

  3. Change in eating behaviour based on 24 hours recall

    Measured: Four weeks before intervention to eight weeks

Secondary outcomes (9)
  1. Enjoyment via affect scale

    Pleasure in using the application. Score from 1-5, higher score means a better outcome.

    Measured: Eight weeks after intervention

  2. Classic aesthetics Scale

    The design of the application. Score from 1-7, higher score means a better outcome.

    Measured: Eight weeks after intervention

  3. Concern for privacy scale

    Concerns about sharing personal data, e.g.name and date of birth. Score from 1-7, higher score means a better outcome.

    Measured: Four and eight weeks after intervention

  4. Active control scale

    Control over the system, as perceived by the user. Score from 1-7, higher score means a better outcome.

    Measured: Eight weeks after intervention

  5. System Usability Scale

    Whether PACO is easy to use. Score from 1-5, higher score means a better outcome.

    Measured: Eight weeks after intervention

  6. Perceived usefulness scale

    Score from 1-5, higher score means a better outcome.

    Measured: Eight weeks after intervention

  7. Rapport scale

    Relationship with the embodied conversational agent. Score from 1-5, higher score means a better outcome.

    Measured: Four weeks before intervention to eight weeks

  8. Brief Older People's Quality of Life Scake

    Score from 1-5, higher score means a better outcome.

    Measured: Four weeks before intervention to eight weeks

  9. Change in Basic Psychological Need Satisfaction and Frustration Scales

    Score from 1-5, higher score means a better outcome.

    Measured: Four weeks before intervention to eight weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2020
  2. Study start13 Jul 2020
  3. Primary completion30 Dec 2020
  4. Study completion30 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Sequential
Model description
An unblinded randomized controlled trial. Participants in the first cohort directly receive the intervention for 8 weeks. Participants in the second cohort receive the intervention after a waiting list condition of 4 weeks, serving as a control group.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
52 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04510883
Sponsor's protocol ID
40-44300-98-110
Status last verified
Apr 2021
First submitted
13 Jul 2020
Last updated
8 Apr 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: In accordance with the Data Management Plan, part of the data will be anonymized and made available in DANS-EASY with restricted access.

Publications

  • Kramer LL, van Velsen L, Clark JL, Mulder BC, de Vet E. Use and Effect of Embodied Conversational Agents for Improving Eating Behavior and Decreasing Loneliness Among Community-Dwelling Older Adults: Randomized Controlled Trial. JMIR Form Res. 2022 Apr 11;6(4):e33974. doi: 10.2196/33974.

    PubMed 35404255
  • Kramer LL, Mulder BC, van Velsen L, de Vet E. Use and Effect of Web-Based Embodied Conversational Agents for Improving Eating Behavior and Decreasing Loneliness Among Community-Dwelling Older Adults: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2021 Jan 6;10(1):e22186. doi: 10.2196/22186.

    PubMed 33404513

Questions about this trial

What is this clinical trial studying?

A study testing PACO and Waiting list + PACO in people with Eating Behavior and Loneliness, run by Wageningen University and Research at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Logdata on use application (time frame: 8 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04510883, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in